MENLO PARK, Calif.--(BUSINESS WIRE)--Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today announced the 10 institutions that have purchased its Single Molecule Real Time (SMRT™) DNA sequencing system as part of the company’s early access program in North America.
